64
Participants
Start Date
March 22, 2023
Primary Completion Date
March 20, 2025
Study Completion Date
March 20, 2025
efgartigimod PH20 SC
Subcutaneous injection of efgartigimod coformulated with rHuPH20, a permeation enhancer
Prednisone
Oral Prednisone
Semmelweis Egyetem, Budapest
Diagnostic and Consulting Center Aleksandrovska EOOD, Sofia
Premier Specialists, Kogarah
Poliklinika Solmed, Zagreb
Charité - Universitätsmedizin Berlin, Berlin
University Clinical Center of Serbia - PPDS, Belgrade
Hospital of Venereal and Skin Diseases A.Syggros, Athens
Ospedale Policlinico San Martino, Genova
Hospital Universitario Clínico San Cecilio, Granada
Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milan
Universitatsklinikum Schleswig-Holstein, Kiel
Fondazione IRCCS Policlinico San Matteo di Pavia, Pavia
Hospital Universitario 12 de Octubre, Madrid
Miami Dermatology and Laser Institute, Miami
Universitatsklinikum Dusseldorf, Düsseldorf
Wright State Physicians, Fairborn
Hospital Universitario Doctor Peset, Valencia
University of Michigan Hospital, Ann Arbor
Azienda USL Toscana Centro - Ospidale Piero Palagi, Florence
Azienda Sanitaria Di Firenze, Florence
Hospital Of Skin And Venereal Diseases of Thessaloniki, Thessaloniki
Saint Louis University, St Louis
LMU Klinikum der Universität, München
Medical Dermatology Specialists, Phoenix
Fakultna nemocnica Trnava, Trnava
First OC Dermatology, Fountain Valley
Azienda Ospedaliero Universitaria Policlinico Vittorio Emanuele, Catania
Universitätsklinikum Würzburg, Würzburg
Ruijin Hospital Shanghai Jiaotong University School of Medicine, Shanghai
The First Affiliated Hospital of Chongqing Medical University, Chongqing
West China Hospital of Sichuan University, Chengdu
Sheba Medical Center - PPDS, Ramat Gan
Fakultni nemocnice Bulovka, Prague
Universitätsklinikum Carl Gustav Carus an der TU Dresden, Dresden
IDI IRCCS - Istituto Dermopatico dell'Immacolata, Roma
Fondazione Policlinico Universitario A. Gemelli, Rome
Hokkaido University Hospital, Sapporo
Universitair Medisch Centrum Groningen, Groningen
Univerzitna nemocnica Bratislava, Bratislava
Guy's and St Thomas' NHS Foundation Trust, London
Lead Sponsor
argenx
INDUSTRY